Clinical Report: Decreased Atrial Fibrillation Recurrence Following Cryoballoon Ablation

Overview

This study investigates the impact of patent foramen ovale (PFO) on atrial fibrillation (AF) recurrence after cryoballoon ablation (CBA). Results indicate that PFO was identified in 16.6% of patients, and AF recurrence occurred in 26.8% of the cohort over a median follow-up of 19 months.

Background

Atrial fibrillation is a common arrhythmia that significantly impacts patient morbidity and healthcare resources. This study focuses on the role of atrial septal anomalies, particularly PFO, in influencing outcomes after CBA.

Data Highlights

Key Findings

• PFO was identified in 16.6% of patients undergoing CBA.
• AF recurrence occurred in 26.8% of the cohort over a median follow-up of 19 months.
• Patients with PFO had a significantly lower AF recurrence rate compared to those without PFO (HR: 0.62).
• The association between PFO and lower AF recurrence was independent of other clinical factors.
• Further prospective studies are warranted to explore the protective role of PFO.

Clinical Implications

The findings indicate the presence of PFO in patients undergoing CBA for AF.

Conclusion

This study reports the association of PFO with AF recurrence following cryoballoon ablation.

Related Resources & Content

1. Clinical Research in Cardiology, 2020 -- Increase in Sinus Rate Following Cryoballoon Pulmonary Vein Isolation in Individuals with Paroxysmal Atrial Fibrillation
2. Clinical Research in Cardiology, 2024 -- Evaluation of Arctic Front Advance Pro versus POLARx Cryoballoons in Atrial Fibrillation Ablation: An Intraprocedural Examination
3. Clinical Research in Cardiology, 2020 -- Post-Ablation Sinus Heart Rate and Long-Term Recurrence Risks in Patients with Atrial Fibrillation
4. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
5. Frontiers, 2026 -- Reduced recurrence of atrial fibrillation after cryoballoon ablation in patients with preprocedural patent foramen ovale
6. Clinical Research in Cardiology — Assessing Temperature and Time: A New Endpoint for Predicting Long-Term Pulmonary Vein Isolation Following Cryoballoon Ablation in Paroxysmal Atrial Fibrillation
7. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
8. Pulsed field ablation versus cryoballoon ablation for pulmonary vein isolation in atrial fibrillation: a systematic review and meta-analysis with subgroup analyses by AF type | BMC Cardiovascular Disorders | Springer Nature Link
9. Frontiers | Reduced recurrence of atrial fibrillation after cryoballoon ablation in patients with preprocedural patent foramen ovale: a retrospective single-center observational cohort study